Heidelberg Pharma AG (HPHA) | WebDisclosure

Basculer en Français

8623	Companies
143099	Keywords
78820	Articles
76460	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 03/13/2025 at 00:36, 1 month 9 days ago

Heidelberg Pharma Modifies Royalty Financing with HealthCare Royalty

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Financing TLX250-CDx
PRESS RELEASE

published on 03/13/2025 at 00:31, 1 month 9 days ago

EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Heidelberg Pharma amends royalty financing agreement with HealthCare Royalty, extending cash runway into 2027 for innovative ADC development. USD 20 million payment provided

Heidelberg Pharma HealthCare Royalty Royalty Financing ADC Development Cash Runway
BRIEF

published on 01/13/2025 at 08:22, 3 months 9 days ago

Heidelberg Pharma fait progresser le HDP-101 dans le cadre d'une étude de phase I/IIa

HDP-101 Myélome Multiple Étude De Phase I/IIa Progrès Clinique Conjugués Anticorps-médicaments
BRIEF

published on 01/13/2025 at 08:22, 3 months 9 days ago

Heidelberg Pharma Advances HDP-101 in Phase I/IIa Study

HDP-101 Multiple Myeloma Phase I/IIa Study Antibody Drug Conjugates Clinical Advancement
PRESS RELEASE

published on 01/13/2025 at 08:17, 3 months 9 days ago

Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
Heidelberg Pharma advances into Cohort 7 with BCMA ATAC candidate HDP-101 targeting multiple myeloma, showing promising results and complete remission in Phase I/IIa study

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study Complete Remission BCMA ATAC
BRIEF

published on 11/06/2024 at 10:07, 5 months 16 days ago

Heidelberg Pharma Reveals Promising Data on HDP-101 at ASH 2024

Clinical Data Heidelberg Pharma HDP-101 ADC Technology Multiple Myeloma
BRIEF

published on 11/06/2024 at 10:07, 5 months 16 days ago

Heidelberg Pharma dévoile des données prometteuses sur le HDP-101 à l'ASH 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Technologie ADC
PRESS RELEASE

published on 11/06/2024 at 10:02, 5 months 16 days ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting
BRIEF

published on 10/24/2024 at 11:08, 5 months 29 days ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
BRIEF

published on 10/24/2024 at 11:08, 5 months 29 days ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201

Accesswire

Published on 04/22/2025 at 15:45, 1 hour 18 minutes ago

Alaska Energy Metals Files Updated NI 43-101 Technical Report for The Eureka Deposit, Nikolai Nickel Project, Alaska, USA
Published on 04/22/2025 at 15:15, 1 hour 48 minutes ago

Silver Bull Announces Voting Results of Annual Meeting of Shareholders
Published on 04/22/2025 at 15:15, 1 hour 48 minutes ago

D. Boral Capital Acted as Exclusive Placement Agent to Safe & Green Holdings Corp. (Nasdaq: SGBX) in Connection with Its Approximately $8.0 Million Private Placement
Published on 04/22/2025 at 15:00, 2 hours 3 minutes ago

BlackBerry Earns FedRAMP High Authorization for Crisis Communication Software
Published on 04/22/2025 at 15:00, 2 hours 3 minutes ago

Vox Royalty Notes Production and Development Milestones on Western Australia Gold Royalty Assets

View all ACCESSWIRE

EQS Group

Published on 04/22/2025 at 16:52, 10 minutes ago

Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Published on 04/22/2025 at 16:00, 1 hour 2 minutes ago

Original-Research: Advanced Blockchain AG (von GBC AG): Buy
Published on 04/22/2025 at 16:00, 1 hour 3 minutes ago

First Phosphate salue le discours électoral fédéral canadien sur le développement des réserves de phosphate igné propre du Québec
Published on 04/22/2025 at 15:09, 1 hour 54 minutes ago

Positive decision in DFL licensing proceeding
Published on 04/22/2025 at 15:02, 2 hours ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated

Les Echos

Published on 04/22/2025 at 15:52, 1 hour 10 minutes ago

Availability of the 2024 Universal Registration Document (URD)
Published on 04/22/2025 at 15:52, 1 hour 10 minutes ago

Mise à disposition du Document d'Enregistrement Universel 2024
Published on 04/22/2025 at 10:00, 7 hours 3 minutes ago

Descriptif du programme de rachat d'actions autorisé par l'Assemblée générale mixte des actionnaires du 17 avril 2025
Published on 04/22/2025 at 10:00, 7 hours 3 minutes ago

Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 17, 2025
Published on 04/22/2025 at 08:30, 8 hours 33 minutes ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 14/04/2025 tot 18/04/2025

View all LES ECHOS COMFI WIRE